Averkaz Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Montelukast Na

Indications/Uses

Management of chronic asthma, allergic rhinitis. Prophylaxis for exercise-induced asthma.

Click to view Averkaz detailed prescribing information

Dosage/Direction for Use

Chewable tab Childn 6-14 yr 5 mg once daily at bedtime. FC tab Adult ≥15 yr 10 mg once daily at bedtime.

Click to view Averkaz detailed prescribing information

Overdosage

View Averkaz overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Hepatic impairment or cirrhosis.

Click to view Averkaz detailed prescribing information

Special Precautions

Not indicated for use in acute asthma attacks. Not to be used as monotherapy for the treatment & management of exercise-induced bronchospasm. Pregnancy & lactation. Safety & effectiveness have not been established in childn <2 yr.

Click to view Averkaz detailed prescribing information

Use In Pregnancy & Lactation

Click to view Averkaz detailed prescribing information

Adverse Reactions

GI disturbances, dry mouth, thirst; hypersensitivity reactions including anaphylaxis, angioedema & skin reactions; asthenia, dizziness, irritability, restlessness, headache, sleep disorders (insomnia, drowsiness, nightmares); URTI, fever, arthralgia, myalgia.

Click to view Averkaz detailed prescribing information

Drug Interactions

Employ appropriate clinical monitoring when co-administered w/ potent CYP450 enzyme inducers eg, phenobarb or rifampin.

Click to view Averkaz detailed prescribing information

Storage

View Averkaz storage conditions for details to ensure optimal shelf-life.

Description

View Averkaz description for details of the chemical structure and excipients (inactive components).

Action

View Averkaz mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

Averkaz chewable tab 5 mg

Packing/Price

30's

Form

Averkaz FC tab 10 mg

Packing/Price

15's

Averkaz

montelukast

Manufacturer:

ACME

Distributor:

Euro Generics